Highlights HLB Therapeutics Co.,Ltd.

Equities

A115450

KR7115450009

End-of-day quote Korea S.E. Other stock markets 03:30:00 03/06/2024 am IST			5-day change	1st Jan Change
7,630 ^KRW	-9.92%		-5.45%	+74.00%

16/05	HLB Therapeutics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/04	HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

HLB Therapeutics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
HLB Therapeutics Submits Phase 3 Protocol for Neurotrophic Keratopathy	27/22/27	CI
HLB Therapeutics Signs Letter of Intent with Global Ophthalmology CRO for Two Phase 3 Clinical Trials in Neurotrophic Keratitis	18/22/18	CI
G-Tree Holdings Co.,Ltd. completed the acquisition of 2.65% stake in G-treeBNT Co., Ltd. from Yang Won-seok for KRW 16.9 billion.	26/21/26	CI
G-Tree Holdings Co.,Ltd. agreed to acquire 3.92% stake in G-treeBNT Co., Ltd. from Yang Won-seok for KRW 35.9 billion.	29/20/29	CI
An unknown buyer completed the acquisition of 4.7% stake in G-treeBNT Co., Ltd. from Yuyang D&U Co.,Ltd. for KRW 15.3 billion.	20/20/20	CI
GtreeBNTCo., Ltd. Issues Update on the U.S. Phase 3 Clinical Trial	03/20/03	CI
RegeneRx Biopharmaceuticals, Inc. and GtreeBNT Provide Updates on Clinical Trials	29/18/29	CI
G-treeBNT Co., Ltd. completed the acquisition of YS Pharm Co., Ltd.	04/18/04	CI
GtreeBNT Enters Joint Venture with YuYang DNU to Develop RGN-137 for Treatment of Epidermolysis Bullosa	02/18/02	CI
G-treeBNT Co., Ltd. agreed to acquire YS Pharm Co., Ltd. for KRW 6.7 billion.	02/18/02	CI
Yuyang D&U Co.,Ltd. completed the acquisition of a 14.4% stake in G-treeBNT Co., Ltd. from G-tree Fund 1.	10/17/10	CI
Yuyang D&U Co.,Ltd. agreed to acquire a 14.4% stake in G-treeBNT Co., Ltd. from G-tree Fund 1 for KRW 53.5 billion.	26/16/26	CI
Point-I Co., Ltd. completed the acquisition of Kim Jong Hak Production, Inc. from G-treeBNT Co., Ltd..	30/15/30	CI
Regenerx Biopharmaceuticals and G-treeBNT Co., Ltd. Partner to Develop RGN-259 in the US for Ophthalmic Indications	29/15/29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights HLB Therapeutics Co.,Ltd.

Equities

A115450

KR7115450009

Highlights

Filters